Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine
- 1 June 1995
- Vol. 3 (6) , 581-590
- https://doi.org/10.1016/s0969-2126(01)00192-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Determinants of repressor/operator recognition from the structure of the trp operator binding siteNature, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Crystal structure of a complex of HIV‐1 protease with a dihydroxyethylene‐containing inhibitor: Comparisons with molecular modelingProtein Science, 1992
- Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodiesGene, 1990
- OMITMAP: An electron density map suitable for the examination of errors in a macromolecular modelJournal of Applied Crystallography, 1984